Pma/510(k): k130520.The actual device was returned for evaluation.Visual inspection upon receipt found the formation of aggregated red thrombus inside the cardiotomy filter component.It did not find any visible break on it.The cardiotomy filter component was taken out of the reservoir.Visual inspection of the filter and the defoamer set inside the filter found aggregated red thrombus forming on the inner and outer surfaces of the filter and on the inner surface of the defoamer.The venous filter component was taken out of the reservoir.Visual inspection of the filter and the defoamer set inside the filter did not find any aggregated red thrombus like the one found in the cardiotomy filter component.Electron microscopic evaluation of the filter of the cardiotomy filter component revealed the adhesion of red blood cells, deformed red blood cells (echinocytes) and the formation of fibrin net.Electron microscopic evaluation of the defoamer of the cardiotomy filter component, focusing on the segment where red thrombus had formed revealed the adhesion of red blood cells, deformed red blood cells (echinocytes) and the formation of fibrin net.There was no presence of red thrombus on the outer surface.Electron microscopic evaluation of the filter of the venous filter component revealed the adhesion of red blood cells and the formation of fibrin net.Electron microscopic evaluation of the defoamer of the venous filter component revealed no adhesion of red blood cells.A review of the device history record and shipping inspection record of the involved product code/lot number combination revealed no findings.Ifu reference: adequate heparinization of the blood is required to prevent it from clotting.Do not reduce heparin during circulation.Otherwise, blood clotting might occur.There is no evidence that this event was related to a device defect or malfunction.The exact cause of the reported event cannot be definitively determined based on the available information.(b)(4).
|